CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insider trading

CRLNYSE

$290.19+3.36 (+1.17%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+65.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

JCJames C. FosterDirector0.4889%of company
BGBirgit GirshickChief Executive Officer0.1661%of company
SMShannon M. ParisottoCEVP, Disc & Safety Assessment0.0901%of company
RFRichard F. WallmanDirector0.0658%of company
JWJoseph W. LaPlumeEVP, Corp Strategy & Develop0.065%of company
VLVictoria L. CreamerEVP & Chief People Officer0.0629%of company
GCGlenn ColemanEVP & Chief Financial Officer0.0582%of company
WDWilliam D. BarboCorporate Executive VP & CCO0.0541%of company
FPFlavia PeaseCorporate Executive VP & CFO0.0362%of company
MMMartin MacKayDirector0.0359%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
CRL	Glenn ColemanEVP & Chief Financial Officer	Open market purchase$2.97K	0.0%	$297.43	$2.97K	Sep 30, 2026	Oct 2, 2026
CRL	Shannon M. ParisottoCEVP, Disc & Safety Assessment	Open market sell$1.33M	-10.5%	$263.00	$1.33M	Aug 5, 2026	Aug 6, 2026
CRL	James C. FosterDirector	Open market sell$16.9M	-24.3%	$225.00	$16.9M	Jun 29, 2026	Jul 1, 2026
CRL	Joseph W. LaPlumeEVP, Corp Strategy & Develop	Open market purchase$4.36K	+0.1%	$174.54	$4.36K	Mar 3, 2026	Mar 4, 2026

End of history · 4 transactions